News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
218 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Business
AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte
Astra and Incyte are pushing forward on the development of immunotherapy combination treatments.
October 31, 2017
·
2 min read
·
Alex Keown
Deals
Cancer Biotech Apellis Pharma Sets Terms for $150M IPO
The Crestwood, KY-based company plans to raise $150M by offering 10.7 million shares at a price range of $13 to $15.
October 31, 2017
·
1 min read
Business
Kirin Cashes Out of Amgen Drug Joint Venture for $780M
Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen.
October 31, 2017
·
2 min read
·
Mark Terry
Lone Star Bio
Houston Medtech Firm Corinnova Scores $6.1M
Corinnova’s CEO says the company has developed a device called EpicHeart to tackle heart failure.
October 31, 2017
·
1 min read
Pharm Country
Bristol-Myers, Johnson & Johnson Get in on Europeon Biotech Fund’s $95M Raise
The money is intended to to fuel European biotech startups.
October 31, 2017
·
1 min read
Deals
3 Biotechs Bloodied Celgene Could Take Out
Investors and analysts are wondering if the company should buy a biotech to bolster its pipeline and bottom line.
October 31, 2017
·
2 min read
·
Mark Terry
Business
X-Spine Systems to Shut Down, Lays Off 54 Employees
X-Spine is shutting down its Ohio facility and terminating the employees between December and February 2018.
October 31, 2017
·
2 min read
·
Alex Keown
Business
Voyager Sinks as Sanofi Genzyme Opts Out of Parkinson’s Gene Therapy Program
Shares of Voyager have fallen more than 12 percent in premarket trading after Sanofi Genzyme walked away from its $845M gene therapy treatment for Parkinson’s disease.
October 31, 2017
·
2 min read
·
Alex Keown
Business
Grail CSO Exits to Join Bay Area VC Firm Foresite Capital
Vikram Bajaj joined Grail only a year ago.
October 31, 2017
·
1 min read
Business
Lundbeck Names Interim Leader, Effective Nov. 1, 2017
Anders Gotzsche will serve as interim CEO while the company looks for a replacement for Kare Schultz who leaves the company Oct. 31 for the CEO position at Teva.
October 31, 2017
·
2 min read
·
Alex Keown
1 of 22
Next
